Total Payments
$265,211
2024 Payments
$1,492
Companies
45
Transactions
734
Medicare Patients
13,737
Medicare Billing
$1.3M
Payment Breakdown by Category
Research$254,443 (95.9%)
Food & Beverage$10,768 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $254,443 | 17 | 95.9% |
| Food and Beverage | $10,768 | 717 | 4.1% |
Payments by Type
Research
$254,443
17 transactions
General
$10,768
717 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intercept Pharmaceuticals, Inc. | $254,753 | 36 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,586 | 227 | $0 (2024) |
| ABBVIE INC. | $1,866 | 110 | $0 (2024) |
| QOL Medical, LLC | $885.48 | 51 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $636.98 | 36 | $0 (2024) |
| UCB, Inc. | $536.81 | 30 | $0 (2020) |
| Janssen Biotech, Inc. | $462.41 | 28 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $345.67 | 20 | $0 (2023) |
| Celgene Corporation | $332.50 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $288.23 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,492 | 79 | ABBVIE INC. ($269.96) |
| 2023 | $1,637 | 86 | AbbVie Inc. ($327.98) |
| 2022 | $1,871 | 113 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($558.21) |
| 2021 | $1,749 | 132 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($600.00) |
| 2020 | $804.83 | 71 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($410.51) |
| 2019 | $255,768 | 112 | Intercept Pharmaceuticals, Inc. ($254,521) |
| 2018 | $825.81 | 66 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($239.56) |
| 2017 | $1,062 | 75 | Valeant Pharmaceuticals North America LLC ($228.03) |
All Payment Transactions
734 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $27.11 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: GI | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.64 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: Neuroscience | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| 1009742 | INTERCEPT PHARMACEUTICALS, INC. | $170,002 | 10 |
| 1011866 | INTERCEPT PHARMACEUTICALS, INC. | $84,441 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 4,121 | 4,980 | $2.3M | $385,812 |
| 2022 | 22 | 4,073 | 4,719 | $2.3M | $382,097 |
| 2021 | 20 | 2,649 | 2,843 | $1.5M | $283,400 |
| 2020 | 22 | 2,894 | 3,073 | $1.5M | $292,471 |
Total Patients
13,737
Total Services
15,615
Medicare Billing
$1.3M
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 630 | 850 | $153,000 | $48,785 | 31.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 340 | 341 | $301,210 | $48,446 | 16.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 185 | 188 | $221,276 | $38,558 | 17.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 531 | 531 | $132,750 | $37,267 | 28.1% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 51 | 51 | $134,450 | $27,359 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 261 | 261 | $91,350 | $26,729 | 29.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 286 | 375 | $121,875 | $22,962 | 18.8% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 298 | 449 | $145,925 | $22,316 | 15.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 472 | 785 | $282,600 | $19,045 | 6.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 320 | 323 | $245,480 | $17,713 | 7.2% |
| 46221 | Removal of external hemorrhoids by rubber banding | Facility | 2023 | 49 | 108 | $64,800 | $14,641 | 22.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 146 | 150 | $104,810 | $14,160 | 13.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 65 | 65 | $51,208 | $11,025 | 21.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 61 | 61 | $53,680 | $10,686 | 19.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 65 | 65 | $57,200 | $8,059 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 52 | $13,000 | $4,228 | 32.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 56 | 57 | $37,905 | $3,914 | 10.3% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 16 | 16 | $11,040 | $2,435 | 22.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 58 | 59 | $5,605 | $2,340 | 41.7% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 106 | 117 | $23,400 | $2,338 | 10.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 20 | $3,600 | $868.02 | 24.1% |
| 45331 | Biopsy of lower large bowel using a flexible endoscope | Facility | 2023 | 12 | 13 | $5,200 | $580.24 | 11.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 13 | 13 | $3,250 | $573.77 | 17.7% |
| 76705 | Limited ultrasound scan of abdomen | Facility | 2023 | 18 | 18 | $2,250 | $397.44 | 17.7% |
| 45330 | Diagnostic exam of lower portion of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $4,080 | $387.27 | 9.5% |
About Dr. Jeffrey Williams, MD
Dr. Jeffrey Williams, MD is a Gastroenterology healthcare provider based in Athens, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407822158.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Williams, MD has received a total of $265,211 in payments from pharmaceutical and medical device companies, with $1,492 received in 2024. These payments were reported across 734 transactions from 45 companies. The most common payment nature is "" ($254,443).
As a Medicare-enrolled provider, Williams has provided services to 13,737 Medicare beneficiaries, totaling 15,615 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Athens, GA
- Active Since 02/23/2006
- Last Updated 09/21/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407822158
Products in Payments
- OCALIVA (Drug) $84,752
- XIFAXAN (Drug) $2,006
- Cimzia (Drug) $536.81
- Sucraid (Drug) $531.33
- STELARA (Biological) $424.52
- CREON (Drug) $396.16
- DUPIXENT (Biological) $392.71
- ENTYVIO (Biological) $383.80
- TRULANCE (Drug) $379.24
- SUCRAID (Drug) $354.15
- ZEPOSIA (Drug) $350.58
- LINZESS (Drug) $315.73
- MAVYRET (Drug) $313.35
- VIBERZI (Drug) $251.13
- DIFICID (Drug) $205.16
- MOVIPREP (Drug) $182.24
- XELJANZ (Drug) $171.78
- RELISTOR (Drug) $166.46
- Entyvio (Biological) $163.93
- Mavyret (Drug) $154.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Athens
Dr. Gregory Smith, Medical Doctor, MEDICAL DOCTOR
Gastroenterology — Payments: $32,655
Gastroenterology $32,655
Minesh Mehta, M.d, M.D
Gastroenterology — Payments: $32,439
Gastroenterology $32,439
Kelly Grow, Md, MD
Gastroenterology — Payments: $12,213
Gastroenterology $12,213
Dr. Brian Torski, D.o, D.O
Gastroenterology — Payments: $3,745
Gastroenterology $3,745
Srikar Mapakshi, M.d, M.D
Gastroenterology — Payments: $3,441
Gastroenterology $3,441
Lance Mcleroy, Md, MD
Gastroenterology — Payments: $2,938
Gastroenterology $2,938